CRTH2 Mediates Profibrotic Macrophage Differentiation and Promotes Lung Fibrosis
Authors:
- 1 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 67 (2) , 201-214
Abstract
Idiopathic pulmonary fibrosis (IPF) is a particularly deadly form of pulmonary fibrosis of unknown cause. In patients with IPF, high serum and lung concentrations of CHI3L1 (chitinase 3 like 1) can be detected and are associated with poor survival. However, the roles of CHI3L1 in these diseases have not been fully elucidated. We hypothesize that CHI3L1 interacts with CRTH2 (chemoattractant receptor–homologous molecule expressed on T-helper type 2 cells) to stimulate profibrotic macrophage differentiation and the development of pulmonary fibrosis and that circulating blood monocytes from patients with IPF are hyperresponsive to CHI3L1–CRTH2 signaling. We used murine pulmonary fibrosis models to investigate the role of CRTH2 in profibrotic macrophage differentiation and fibrosis development and primary human peripheral blood mononuclear cell culture to detect the difference of monocytes in the responses to CHI3L1 stimulation and CRTH2 inhibition between patients with IPF and normal control subjects. Our results showed that null mutation or small-molecule inhibition of CRTH2 prevents the development of pulmonary fibrosis in murine models. Furthermore, CHI3L1 stimulation induces a greater increase in CD206 expression in IPF monocytes than control monocytes. These results demonstrated that monocytes from patients with IPF appear to be hyperresponsive to CHI3L1 stimulation. These studies support targeting the CHI3L1–CRTH2 pathway as a promising therapeutic approach for IPF and that the sensitivity of blood monocytes to CHI3L1-induced profibrotic differentiation may serve as a biomarker that predicts responsiveness to CHI3L1- or CRTH2-based interventions.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01 HL146498)
- National Institute of General Medical Sciences (P20 GM103652)
- National Institute of General Medical Sciences (U54 GM115677)
- National Heart, Lung, and Blood Institute (R01 HL146498)
- National Institute of General Medical Sciences (P20 GM103652)
- National Institute of General Medical Sciences (U54 GM115677)
This publication has 54 references indexed in Scilit:
- Molecular and cellular mechanisms of pulmonary fibrosisFibrogenesis & Tissue Repair, 2012
- Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosisFibrogenesis & Tissue Repair, 2011
- Role of Chitin and Chitinase/Chitinase-Like Proteins in Inflammation, Tissue Remodeling, and InjuryAnnual Review of Physiology, 2011
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid PThe International Journal of Biochemistry & Cell Biology, 2011
- The Chitinase-like Proteins Breast Regression Protein-39 and YKL-40 Regulate Hyperoxia-induced Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13–induced tissue responses and apoptosisJournal of Experimental Medicine, 2009
- The Clinical Course of Patients with Idiopathic Pulmonary FibrosisAnnals of Internal Medicine, 2005
- Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 ReceptorThe Journal of Pharmacology and Experimental Therapeutics, 2005
- The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathwaysBiochemical Journal, 2002